Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04765436
Brief Title: PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64

First Submitted : February 16, 2021
First Submitted that Met QC Criteria : February 19, 2021
First Posted : February 21, 2021

Last Update Submitted that Met QC Criteria : June 28, 2021
Last Update Posted : June 30, 2021